TABLE 3.
Pregnancy outcomes of the study population a
| Pregnancy outcome | Number of women (n = 575) |
|---|---|
| Miscarriage/ectopic pregnancy/molar pregnancy | 31 (5.4) |
| Termination of pregnancy | 2 (0.3) |
| Delivery | 542 (94.3) |
| Delivery outcome | Number of women (n = 542) |
| Gestational age at time of delivery (weeks) (n = 505) | |
| 22–27 | 12 (2.4) |
| 28–31 | 25 (5.0) |
| 32–36 | 142 (28.1) |
| ≥37 | 326 (64.6) |
| Mode of delivery (n = 502) | |
| Normal vertex delivery | 177 (35.3) |
| Breech vaginal delivery | 4 (0.8) |
| Assisted (vacuum/forceps) vaginal delivery | 5 (1.0) |
| Cesarean delivery before labor | 180 (35.9) |
| Cesarean delivery during labor | 136 (27.1) |
| Primary indication for cesarean delivery (n = 316) | |
| Fetal distress | 99 (31.3) |
| Previous cesarean delivery | 92 (29.1) |
| Maternal medical condition | 27 (8.5) |
| Pre‐eclampsia/eclampsia | 22 (7.0) |
| Failure of labor to progress | 15 (4.7) |
| Other | 12 (3.8) |
| Placental abruption | 9 (2.8) |
| Failed induction | 9 (2.8) |
| Abnormal fetal presentation | 8 (2.5) |
| Placenta previa | 6 (1.9) |
| Cephalo‐pelvic disproportion | 4 (1.3) |
| Previous uterine surgery | 3 (0.9) |
| Multiple gestation | 3 (0.9) |
| Premature rupture of membranes | 3 (0.9) |
| Suspected fetal growth restriction | 2 (0.6) |
| Reduced fetal movement | 1 (0.3) |
| Unknown | 1 (0.3) |
| Timing of COVID‐19 infection and delivery (n = 524) | |
| COVID‐19 >7 days before delivery | 195 (37.2) |
| COVID‐19 within 7 days before delivery | 230 (43.9) |
| COVID‐19 within 7 days after delivery | 76 (14.5) |
| COVID‐19 >7 days after delivery | 23 (4.4) |
| Neonatal outcome | Number of infants (n = 551) |
| Birth weight (g) (n = 520) | |
| <1000 | 11 (2.1) |
| 1000–1499 | 19 (3.7) |
| 1500–2499 | 116 (22.3) |
| ≥2500 | 374 (71.9) |
| Congenital abnormality (n = 535) | 18 (3.4) |
| Perinatal death (n = 530) | 37 (7.0) |
| Primary cause of perinatal death (n = 37) | |
| Stillbirth | 25 (67.6) |
| Complications of prematurity | 5 (13.5) |
| Birth asphyxia | 2 (5.4) |
| Congenital abnormality | 2 (5.4) |
| Other | 2 (5.4) |
| Unknown cause of neonatal death | 1 (2.7) |
| Neonatal admission to high care/intensive care unit (n = 526 infants born alive) | 162 (30.8) |
| Neonatal complications (n = 526 infants born alive) | |
| Infants without complications | 395 (75.1) |
| Infants with ≥1 complication | 112 (21.3) |
| Respiratory distress syndrome | 81 (15.4) |
| Other | 27 (5.1) |
| Severe jaundice requiring phototherapy | 23 (4.4) |
| Severe infection | 14 (2.7) |
| Neonatal encephalopathy | 6 (1.1) |
| Necrotizing enterocolitis | 3 (0.6) |
| Intraventricular hemorrhage | 2 (0.4) |
| Chronic lung disease | 1 (0.2) |
a
Values are given as number (percentage).